[Clinical course of severe influenza-A/H1N1 infection with fulminant lung failure].
Alb
M
M
Thiel
M
M
Kalenka
A
A
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D015199:Extracorporeal Membrane Oxygenation; D005260:Female; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype; D007251:Influenza, Human / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy*; D007442:Intubation, Intratracheal; D008297:Male; D008875:Middle Aged; D011175:Positive-Pressure Respiration; D012128:Respiratory Distress Syndrome / Q000209:etiology; D012131:Respiratory Insufficiency / Q000209:etiology*; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D000998:Antiviral Agents